<unk>  has been used with some success to treat venous insufficiency. It<unk> imulates blood fibrinolysis and has been evaluated for the treatment of the more advanced skin changes in venous disease such as lipodermatosclerosis. Several randomized trials noted improvement in the area of lipodermatosclerosis, reduced skin thickness, and possibly faster ulcer healing rates with<unk> . It is also being<unk> udied to treat hereditary angioedema, osteoporosis, and skeletal muscle injury.
Stanozolol
Nadolol
Betaxolol
Atenolol
Oxprenolol
Acebutolol
Pindolol
Carteolol